United Therapeutics | UTHR - Ebitda


United Therapeutics reported $355M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
Amarin USD 12.54M 28.57M Jun/2025
Ardelyx USD -29.77M 35.79M Mar/2026
Baxter International USD 309M 756M Mar/2026
Bayer EUR 2.14B 2.31B Jun/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 649.7M 76.5M Mar/2026
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Gilead Sciences USD 3.51B 489M Mar/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Halozyme Therapeutics USD 328.81M 109.24M Jun/2026
Insmed USD -148.3M 165.88M Mar/2026
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
J&J USD 8.27B 1.08B Mar/2026
Lexicon Pharmaceuticals USD -12.04M 15.95M Sep/2025
Moderna USD -1.26B 468M Mar/2026
Omeros USD -47.96M 7.39M Sep/2023
Pfizer USD 6.01B 18M Jun/2026
PTC Therapeutics USD 61.98M 132.97M Mar/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Sarepta Therapeutics USD 375.48M 627.68M Mar/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026
United Therapeutics USD 355M 11.1M Jun/2026
Vertex Pharmaceuticals USD 1.33B 130.5M Jun/2026